AKTS

Aktis Oncology, Inc.CIK 2035832 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

$517.2K

4 trades · 1 insiders

Net · 90d

$-517.2K

Insiders on file

AI insights for AKTS PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for AKTS

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

■ Open-market buys (P) ■ Open-market sales (S) · daily dollar value by transaction date

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Czibere Akos	Chief Medical Officer	13	$0	$1.91M	2026-09-23
Herrmann Ken	Director	9	$0	$196.5K	2026-07-20
Ron-Bigger Shulamit	Chief Operating Officer	5	$0	$1.39M	2026-07-08
Gormley Glenn	Director	1	$0	$0	2026-04-15
VIDA VENTURES II-A, LLC	10% Owner	8	$15.03M	$0	2026-01-12
MPM ONCOLOGY INNOVATIONS FUND LP	10% Owner	7	$20.03M	$0	2026-01-12
Segal Lloyd Mitchell	Director	3	$0	$0	2026-01-12
Foley Todd	Director, 10% Owner	7	$4.19M	$0	2026-01-12
NODELMAN OLEG	Director	12	$40.00M	$0	2026-01-12
Kim Helen Susan	Director, 10% Owner	8	$15.03M	$0	2026-01-12
GADICKE ANSBERT	10% Owner	7	$20.03M	$0	2026-01-12
Boller Kenneth	Interim CFO	37	$30.0K	$167.3K	2024-01-29
Shealy Jeffrey B.	Chief Executive Officer	70	$655.0K	$14.21M	2024-01-29
Aichele David	VP of Business Development	52	$40.0K	$780.5K	2024-01-29
Geiss Arthur	Director	25	$55.0K	$187.0K	2024-01-29
Petock Michelle	Director	2	$0	$0	2023-11-06
McGuire James Michael	Director	7	$100.0K	$0	2023-11-06
McMahon Jeffrey	Director	15	$30.0K	$587.6K	2023-11-06
Denbaars Steven	Director	36	$30.0K	$928.7K	2023-11-06
RUDY SUZANNE B	Director	19	$50.6K	$307.3K	2023-11-06
NEAL JERRY D	Director	13	$1.16M	$0	2023-11-06
Houlden Rohan	Chief Product Officer	23	$0	$1.74M	2021-08-23
MILLER STEVEN P	Director	7	$144.0K	$0	2018-11-09
KURTZWEIL JOHN T	Chief Financial Officer	4	$0	$114.6K	2018-09-28
Tompkins Mark N.	10% Owner	27	$0	$1.44M	2017-12-28
Payne Cindy	Other	2	$0	$0	2017-09-27
Boomgarden Mark	Vice President of Operations	3	$0	$629.3K	2017-06-05

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Czibere Akos	Chief Medical Officer	M Exercise deriv	2026-09-23	2026-09-24	12,500	—	$0	208,718	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-09-23	2026-09-24	7,401	$21.03	$155.6K	0	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-09-23	2026-09-24	5,099	$20.19	$102.9K	7,401	SEC↗
Czibere Akos	Chief Medical Officer	M Exercise	2026-09-23	2026-09-24	12,500	$4.95	$61.9K	12,500	SEC↗
Czibere Akos	Chief Medical Officer	M Exercise deriv	2026-09-23	2026-09-24	12,500	—	$0	208,718	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-09-23	2026-09-24	7,401	$21.03	$155.6K	0	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-09-23	2026-09-24	5,099	$20.19	$103.0K	7,401	SEC↗
Czibere Akos	Chief Medical Officer	M Exercise	2026-09-23	2026-09-24	12,500	$4.95	$61.9K	12,500	SEC↗
Herrmann Ken	Director	M Exercise deriv	2026-07-20	2026-07-21	1,350	—	$0	18,364	SEC↗
Herrmann Ken	Director	M Exercise deriv	2026-07-20	2026-07-21	3,506	—	$0	0	SEC↗
Herrmann Ken	Director	M Exercise	2026-07-20	2026-07-21	3,506	$0.08	$280	3,506	SEC↗
Herrmann Ken	Director	M Exercise	2026-07-20	2026-07-21	1,350	$1.91	$2.6K	4,856	SEC↗
Herrmann Ken	Director	S Sale	2026-07-20	2026-07-21	3,506	$24.56	$86.1K	1,350	SEC↗
Herrmann Ken	Director	S Sale	2026-07-20	2026-07-21	1,350	$24.56	$33.2K	0	SEC↗
Herrmann Ken	Director	M Exercise deriv	2026-07-17	2026-07-20	3,065	—	$0	3,506	SEC↗
Herrmann Ken	Director	S Sale	2026-07-17	2026-07-20	3,065	$25.21	$77.3K	0	SEC↗
Herrmann Ken	Director	M Exercise	2026-07-17	2026-07-20	3,065	$0.08	$245	3,065	SEC↗
Czibere Akos	Chief Medical Officer	M Exercise deriv	2026-07-08	2026-07-10	50,000	—	$0	221,218	SEC↗
Ron-Bigger Shulamit	Chief Operating Officer	M Exercise deriv	2026-07-08	2026-07-10	50,000	—	$0	217,888	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-07-08	2026-07-10	4,371	$28.71	$125.5K	0	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-07-08	2026-07-10	30,829	$27.95	$861.7K	4,371	SEC↗
Czibere Akos	Chief Medical Officer	S Sale	2026-07-08	2026-07-10	14,800	$27.13	$401.5K	35,200	SEC↗
Czibere Akos	Chief Medical Officer	M Exercise	2026-07-08	2026-07-10	50,000	$4.95	$247.5K	50,000	SEC↗
Ron-Bigger Shulamit	Chief Operating Officer	S Sale	2026-07-08	2026-07-10	15,800	$27.13	$428.7K	34,200	SEC↗
Ron-Bigger Shulamit	Chief Operating Officer	M Exercise	2026-07-08	2026-07-10	50,000	$3.66	$183.0K	50,000	SEC↗
Ron-Bigger Shulamit	Chief Operating Officer	S Sale	2026-07-08	2026-07-10	30,000	$27.94	$838.2K	4,200	SEC↗
Ron-Bigger Shulamit	Chief Operating Officer	S Sale	2026-07-08	2026-07-10	4,200	$28.75	$120.8K	0	SEC↗
Gormley Glenn	Director	A Award deriv	2026-04-15	2026-04-16	37,866	—	$0	37,866	SEC↗
Kim Helen Susan	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-12	411,750	—	$0	0	SEC↗
Kim Helen Susan	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-12	3,648,750	—	$0	0	SEC↗
Kim Helen Susan	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-12	101,250	—	$0	0	SEC↗
Kim Helen Susan	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-12	14,838,250	—	$0	0	SEC↗
Segal Lloyd Mitchell	Director	C Conversion deriv	2026-01-12	2026-01-12	50,000	—	$0	0	SEC↗
Segal Lloyd Mitchell	Director	C Conversion deriv	2026-01-12	2026-01-12	24,687	—	$0	0	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	C Conversion deriv	2026-01-12	2026-01-12	3,648,750	—	$0	0	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	C Conversion deriv	2026-01-12	2026-01-12	101,250	—	$0	0	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	C Conversion deriv	2026-01-12	2026-01-12	411,750	—	$0	0	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	C Conversion deriv	2026-01-12	2026-01-12	14,838,250	—	$0	0	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	102,500	—	$0	0	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	86,222	—	$0	86,222	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	965,190	—	$0	965,190	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	2,397,500	—	$0	0	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	488,891	—	$0	0	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	997,299	—	$0	0	SEC↗
NODELMAN OLEG	Director	C Conversion deriv	2026-01-12	2026-01-12	9,913,810	—	$0	0	SEC↗
GADICKE ANSBERT	10% Owner	C Conversion deriv	2026-01-12	2026-01-14	22,500,000	—	$0	0	SEC↗
GADICKE ANSBERT	10% Owner	C Conversion deriv	2026-01-12	2026-01-14	5,000,000	—	$0	0	SEC↗
GADICKE ANSBERT	10% Owner	C Conversion deriv	2026-01-12	2026-01-14	6,000,000	—	$0	0	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	C Conversion deriv	2026-01-12	2026-01-14	5,000,000	—	$0	0	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	C Conversion deriv	2026-01-12	2026-01-14	6,000,000	—	$0	0	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	C Conversion deriv	2026-01-12	2026-01-14	22,500,000	—	$0	0	SEC↗
Foley Todd	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-14	10,227,273	—	$0	0	SEC↗
Foley Todd	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-14	2,727,273	—	$0	0	SEC↗
Foley Todd	Director, 10% Owner	C Conversion deriv	2026-01-12	2026-01-14	2,272,727	—	$0	0	SEC↗
Kim Helen Susan	Director, 10% Owner	P Buy	2026-01-12	2026-01-12	812,455	$18.00	$14.62M	5,671,825	SEC↗
Kim Helen Susan	Director, 10% Owner	C Conversion	2026-01-12	2026-01-12	134,842	—	$0	134,842	SEC↗
Kim Helen Susan	Director, 10% Owner	P Buy	2026-01-12	2026-01-12	22,545	$18.00	$405.8K	157,387	SEC↗
Kim Helen Susan	Director, 10% Owner	C Conversion	2026-01-12	2026-01-12	4,859,370	—	$0	4,859,370	SEC↗
Segal Lloyd Mitchell	Director	C Conversion	2026-01-12	2026-01-12	19,631	—	$0	19,631	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	P Buy	2026-01-12	2026-01-12	812,455	$18.00	$14.62M	5,671,825	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	C Conversion	2026-01-12	2026-01-12	134,842	—	$0	134,842	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	P Buy	2026-01-12	2026-01-12	22,545	$18.00	$405.8K	157,387	SEC↗
VIDA VENTURES II-A, LLC	10% Owner	C Conversion	2026-01-12	2026-01-12	4,859,370	—	$0	4,859,370	SEC↗
NODELMAN OLEG	Director	P Buy	2026-01-12	2026-01-12	144,443	$18.00	$2.60M	347,305	SEC↗
NODELMAN OLEG	Director	C Conversion	2026-01-12	2026-01-12	2,270,879	—	$0	2,270,879	SEC↗
NODELMAN OLEG	Director	C Conversion	2026-01-12	2026-01-12	202,862	—	$0	202,862	SEC↗
NODELMAN OLEG	Director	C Conversion	2026-01-12	2026-01-12	128,506	—	$0	128,506	SEC↗
NODELMAN OLEG	Director	P Buy	2026-01-12	2026-01-12	2,077,779	$18.00	$37.40M	4,348,658	SEC↗
GADICKE ANSBERT	10% Owner	C Conversion	2026-01-12	2026-01-14	5,914,197	—	$0	7,570,168	SEC↗
GADICKE ANSBERT	10% Owner	C Conversion	2026-01-12	2026-01-14	1,577,119	—	$0	9,147,287	SEC↗
GADICKE ANSBERT	10% Owner	P Buy	2026-01-12	2026-01-14	1,112,777	$18.00	$20.03M	10,260,064	SEC↗
GADICKE ANSBERT	10% Owner	C Conversion	2026-01-12	2026-01-14	1,314,262	—	$0	1,655,971	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	P Buy	2026-01-12	2026-01-14	1,112,777	$18.00	$20.03M	10,260,064	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	C Conversion	2026-01-12	2026-01-14	1,314,262	—	$0	1,655,971	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	C Conversion	2026-01-12	2026-01-14	5,914,197	—	$0	7,570,168	SEC↗
MPM ONCOLOGY INNOVATIONS FUND	10% Owner	C Conversion	2026-01-12	2026-01-14	1,577,119	—	$0	9,147,287	SEC↗
Foley Todd	Director, 10% Owner	C Conversion	2026-01-12	2026-01-14	716,872	—	$0	4,002,533	SEC↗
Foley Todd	Director, 10% Owner	C Conversion	2026-01-12	2026-01-14	597,391	—	$0	597,391	SEC↗
Foley Todd	Director, 10% Owner	P Buy	2026-01-12	2026-01-14	232,870	$18.00	$4.19M	4,235,403	SEC↗
Foley Todd	Director, 10% Owner	C Conversion	2026-01-12	2026-01-14	2,688,270	—	$0	3,285,661	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	P Buy	2024-01-29	2024-01-31	1,310,000	$0.50	$655.0K	2,222,775	SEC↗
Boller Kenneth	CFO	P Buy	2024-01-29	2024-01-31	60,000	$0.50	$30.0K	214,957	SEC↗
Aichele David	EVP of Business Development	P Buy	2024-01-29	2024-01-31	80,000	$0.50	$40.0K	334,622	SEC↗
Geiss Arthur	Director	P Buy	2024-01-29	2024-01-31	50,000	$0.50	$25.0K	415,924	SEC↗
Boller Kenneth	CFO	S Sale	2023-12-18	2023-12-20	1,200	$0.72	$864	154,957	SEC↗
Aichele David	EVP of Business Development	S Sale	2023-12-18	2023-12-20	1,500	$0.72	$1.1K	254,622	SEC↗
Boller Kenneth	CFO	S Sale	2023-11-21	2023-11-22	1,700	$0.59	$1.0K	156,157	SEC↗
Aichele David	EVP of Business Development	S Sale	2023-11-21	2023-11-22	2,600	$0.59	$1.5K	254,122	SEC↗
Petock Michelle	Director	A Award deriv	2023-11-06	2023-11-08	185,000	—	$0	185,000	SEC↗
Denbaars Steven	Director	A Award deriv	2023-11-06	2023-11-08	76,500	—	$0	76,500	SEC↗
Denbaars Steven	Director	A Award	2023-11-06	2023-11-08	38,250	—	$0	325,959	SEC↗
McGuire James Michael	Director	A Award	2023-11-06	2023-11-08	83,500	—	$0	183,534	SEC↗
McMahon Jeffrey	Director	A Award	2023-11-06	2023-11-08	78,250	—	$0	580,164	SEC↗
RUDY SUZANNE B	Director	A Award	2023-11-06	2023-11-08	108,250	—	$0	213,299	SEC↗
Geiss Arthur	Director	A Award	2023-11-06	2023-11-08	138,333	—	$0	365,924	SEC↗
NEAL JERRY D	Director	A Award	2023-11-06	2023-11-08	125,750	—	$0	925,537	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award	2023-09-26	2023-09-28	80,000	—	$0	912,775	SEC↗
Boller Kenneth	CFO	A Award	2023-09-13	2023-09-15	40,000	—	$0	157,857	SEC↗
Aichele David	EVP of Business Development	A Award	2023-09-13	2023-09-15	40,000	—	$0	256,722	SEC↗
Aichele David	EVP of Business Development	S Sale	2023-09-11	2023-09-13	5,300	$1.09	$5.8K	216,722	SEC↗
Boller Kenneth	CFO	S Sale	2023-09-11	2023-09-13	3,900	$1.10	$4.3K	117,857	SEC↗
Denbaars Steven	Director	S Sale	2023-08-18	2023-08-22	7,000	$1.83	$12.8K	287,709	SEC↗
Petock Michelle	Director	A Award	2023-03-23	2023-03-23	24,151	—	$0	24,151	SEC↗
McGuire James Michael	Director	A Award	2023-03-09	2023-03-10	2,002	—	$0	100,034	SEC↗
Boller Kenneth	CFO	S Sale	2023-02-10	2023-02-14	800	$4.37	$3.5K	110,958	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award	2023-01-24	2023-01-24	327,273	$2.75	$900.0K	832,775	SEC↗
Denbaars Steven	Director	A Award	2023-01-24	2023-01-25	18,182	$2.75	$50.0K	294,709	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2022-12-20	2022-12-21	2,340	$2.84	$6.6K	505,502	SEC↗
Boller Kenneth	CFO	S Sale	2022-12-19	2022-12-21	1,200	$2.92	$3.5K	111,758	SEC↗
Aichele David	EVP of Business Development	S Sale	2022-12-19	2022-12-21	1,480	$3.14	$4.6K	215,987	SEC↗
Denbaars Steven	Director	S Sale	2022-12-06	2022-12-08	7,000	$3.57	$25.0K	276,527	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2022-11-28	2022-11-28	1,950	$3.54	$6.9K	507,842	SEC↗
Aichele David	EVP of Business Development	S Sale	2022-11-23	2022-11-28	1,850	$3.52	$6.5K	217,467	SEC↗
Boller Kenneth	CFO	S Sale	2022-11-23	2022-11-28	1,200	$3.52	$4.2K	112,958	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award	2022-11-21	2022-11-23	50,000	—	$0	509,792	SEC↗
Boller Kenneth	CFO	A Award	2022-11-21	2022-11-23	25,000	—	$0	114,158	SEC↗
Aichele David	EVP of Business Development	A Award	2022-11-21	2022-11-23	35,000	—	$0	219,317	SEC↗
RUDY SUZANNE B	Director	A Award deriv	2022-11-10	2022-11-14	113,152	—	$0	113,152	SEC↗
McMahon Jeffrey	Director	A Award deriv	2022-11-10	2022-11-14	84,146	—	$0	84,146	SEC↗
NEAL JERRY D	Director	A Award	2022-11-10	2022-11-14	65,722	—	$0	799,787	SEC↗
Geiss Arthur	Director	A Award	2022-11-10	2022-11-14	72,299	—	$0	227,591	SEC↗
Denbaars Steven	Director	A Award	2022-11-10	2022-11-14	39,982	—	$0	283,527	SEC↗
McGuire James Michael	Director	A Award	2022-11-10	2022-11-14	40,766	—	$0	98,032	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2022-09-09	2022-09-12	3,900	$4.30	$16.8K	459,792	SEC↗
Denbaars Steven	Director	S Sale	2022-09-06	2022-09-08	7,000	$3.90	$27.3K	243,545	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2022-08-29	2022-08-31	3,900	$4.54	$17.7K	463,692	SEC↗
Aichele David	EVP of Business Development	S Sale	2022-08-29	2022-08-31	3,700	$4.53	$16.8K	184,317	SEC↗
Boller Kenneth	CFO	S Sale	2022-08-29	2022-08-31	2,400	$4.53	$10.9K	89,158	SEC↗
Aichele David	EVP of Business Development	S Sale	2022-08-22	2022-08-24	1,480	$4.62	$6.8K	188,017	SEC↗
Boller Kenneth	CFO	S Sale	2022-08-22	2022-08-24	1,500	$4.62	$6.9K	91,558	SEC↗
Aichele David	EVP of Business Development	S Sale	2022-07-18	2022-07-20	2,313	$3.68	$8.5K	189,497	SEC↗
Geiss Arthur	Director	M Exercise deriv	2022-06-20	2022-06-21	10,000	—	$0	0	SEC↗
Geiss Arthur	Director	M Exercise	2022-06-20	2022-06-21	10,000	$1.50	$15.0K	155,292	SEC↗
Denbaars Steven	Director	S Sale	2022-06-06	2022-06-07	7,000	$4.48	$31.4K	250,545	SEC↗
Aichele David	EVP of Business Development	S Sale	2022-04-08	2022-04-12	5,000	$5.93	$29.6K	191,810	SEC↗
Geiss Arthur	Director	M Exercise deriv	2022-02-17	2022-02-22	20,000	—	$0	20,000	SEC↗
Geiss Arthur	Director	M Exercise	2022-02-17	2022-02-22	20,000	$1.50	$30.0K	145,292	SEC↗
Denbaars Steven	Director	M Exercise deriv	2022-02-14	2022-02-15	8,013	—	$0	24,719	SEC↗
Denbaars Steven	Director	M Exercise	2022-02-14	2022-02-15	8,013	$6.24	$50.0K	257,545	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	M Exercise deriv	2022-02-10	2022-02-14	15,000	—	$0	45,000	SEC↗
Boller Kenneth	CFO	A Award deriv	2022-02-10	2022-02-22	15,000	—	$0	15,000	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	M Exercise	2022-02-10	2022-02-14	15,000	$7.12	$106.8K	467,592	SEC↗
Boller Kenneth	CFO	A Award	2022-02-10	2022-02-22	10,000	—	$0	93,058	SEC↗
McGuire James Michael	Director	P Buy	2022-02-07	2022-02-08	17,800	$5.62	$100.0K	57,266	SEC↗
Denbaars Steven	Director	S Sale	2022-01-11	2022-01-13	7,000	$5.91	$41.4K	249,532	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-12-20	2021-12-21	1,480	$6.64	$9.8K	196,810	SEC↗
Boller Kenneth	Interim CFO	S Sale	2021-12-20	2021-12-21	2,100	$6.69	$14.0K	83,058	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2021-12-17	2021-12-21	13,928	$7.01	$97.6K	452,592	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-11-23	2021-11-24	1,850	$6.77	$12.5K	198,290	SEC↗
Boller Kenneth	Interim CFO	S Sale	2021-11-23	2021-11-24	900	$6.97	$6.3K	85,158	SEC↗
RUDY SUZANNE B	Director	S Sale	2021-11-09	2021-11-12	12,731	$8.11	$103.2K	105,049	SEC↗
Geiss Arthur	Director	S Sale	2021-10-29	2021-11-02	10,000	$7.47	$74.7K	125,292	SEC↗
RUDY SUZANNE B	Director	A Award	2021-10-28	2021-11-01	22,543	—	$0	117,780	SEC↗
NEAL JERRY D	Director	A Award	2021-10-28	2021-11-01	27,456	—	$0	734,065	SEC↗
McMahon Jeffrey	Director	A Award	2021-10-28	2021-11-01	17,576	—	$0	501,914	SEC↗
McGuire James Michael	Director	A Award	2021-10-28	2021-11-01	17,030	—	$0	39,466	SEC↗
Geiss Arthur	Director	A Award	2021-10-28	2021-11-01	22,652	—	$0	135,292	SEC↗
Denbaars Steven	Director	A Award	2021-10-28	2021-11-01	16,703	—	$0	256,532	SEC↗
Denbaars Steven	Director	S Sale	2021-10-11	2021-10-13	7,000	$8.08	$56.6K	239,829	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-09-27	2021-09-29	1,388	$10.60	$14.7K	200,140	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award deriv	2021-09-09	2021-09-10	50,000	—	$0	50,000	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award	2021-09-09	2021-09-10	50,000	—	$0	466,520	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-08-30	2021-08-31	1,850	$9.04	$16.7K	201,528	SEC↗
Boller Kenneth	Interim CFO	S Sale	2021-08-30	2021-08-31	900	$10.00	$9.0K	86,058	SEC↗
Aichele David	EVP of Business Development	A Award deriv	2021-08-27	2021-08-31	40,000	—	$0	40,000	SEC↗
Boller Kenneth	Interim CFO	A Award deriv	2021-08-27	2021-08-31	25,000	—	$0	25,000	SEC↗
Aichele David	EVP of Business Development	A Award	2021-08-27	2021-08-31	25,000	—	$0	203,378	SEC↗
Boller Kenneth	Interim CFO	A Award	2021-08-27	2021-08-31	15,000	—	$0	86,958	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2021-08-23	2021-08-24	880	$8.15	$7.2K	132,767	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-08-20	2021-08-24	1,480	$8.23	$12.2K	178,378	SEC↗
Boller Kenneth	Interim CFO	S Sale	2021-08-20	2021-08-24	1,200	$8.24	$9.9K	71,958	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2021-07-19	2021-07-20	1,375	$8.96	$12.3K	133,647	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-07-16	2021-07-20	2,313	$9.37	$21.7K	179,858	SEC↗
Denbaars Steven	Director	S Sale	2021-07-12	2021-07-13	7,000	$9.93	$69.5K	246,829	SEC↗
Denbaars Steven	Director	S Sale	2021-04-12	2021-04-14	7,000	$12.00	$84.0K	253,829	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2021-04-08	2021-04-09	100,000	$12.03	$1.20M	416,520	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2021-04-07	2021-04-09	100,000	$12.51	$1.25M	516,520	SEC↗
Aichele David	EVP of Business Development	S Sale	2021-03-22	2021-03-24	5,000	$13.72	$68.6K	182,171	SEC↗
Boller Kenneth	Interim CFO	S Sale	2021-03-17	2021-03-17	1,442	$13.99	$20.2K	73,158	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2021-03-16	2021-03-17	100,000	$13.32	$1.33M	936,239	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2021-03-15	2021-03-17	100,000	$13.83	$1.38M	1,036,239	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2021-03-15	2021-03-17	1,375	$13.82	$19.0K	135,022	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2021-03-11	2021-03-12	99,800	$14.13	$1.41M	136,397	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2021-02-08	2021-02-10	15,000	$18.00	$270.0K	1,136,239	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	G Gift	2021-02-04	2021-04-09	319,719	—	$0	831,520	SEC↗
Denbaars Steven	Director	S Sale	2021-01-11	2021-01-12	7,000	$13.40	$93.8K	260,829	SEC↗
Geiss Arthur	Director	S Sale	2021-01-08	2021-01-12	2,498	$14.00	$35.0K	112,640	SEC↗
RUDY SUZANNE B	Director	S Sale	2020-12-28	2020-12-30	927	$12.73	$11.8K	95,237	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-12-21	2020-12-23	880	$11.07	$9.7K	236,197	SEC↗
Boller Kenneth	Interim CFO	S Sale	2020-12-21	2020-12-23	1,900	$11.05	$21.0K	74,600	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-12-17	2020-12-18	9,000	$11.34	$102.1K	1,151,239	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-12-16	2020-12-18	25,000	$10.25	$256.3K	1,160,239	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-12-11	2020-12-14	3,000	$8.62	$25.9K	187,171	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-12-10	2020-12-11	50,000	$8.51	$425.5K	1,185,239	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-12-09	2020-12-11	50,000	$8.51	$425.5K	1,235,239	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-11-24	2020-11-25	50,000	$7.71	$385.5K	1,285,239	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-11-24	2020-11-25	1,100	$7.70	$8.5K	237,077	SEC↗
Boller Kenneth	Interim CFO	S Sale	2020-11-24	2020-11-25	500	$7.66	$3.8K	76,500	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-11-23	2020-11-25	50,000	$7.77	$388.5K	1,335,239	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-11-23	2020-11-25	1,850	$8.00	$14.8K	190,171	SEC↗
RUDY SUZANNE B	Director	S Sale	2020-11-13	2020-11-17	11,132	$7.83	$87.2K	96,164	SEC↗
Geiss Arthur	Director	S Sale	2020-11-11	2020-11-12	9,343	$7.85	$73.3K	115,138	SEC↗
Geiss Arthur	Director	S Sale	2020-11-09	2020-11-12	463	$8.51	$3.9K	124,481	SEC↗
McMahon Jeffrey	Director	A Award deriv	2020-10-29	2020-10-30	39,704	—	$0	39,704	SEC↗
NEAL JERRY D	Director	A Award	2020-10-29	2020-10-30	31,011	—	$0	706,609	SEC↗
Geiss Arthur	Director	A Award	2020-10-29	2020-10-30	25,585	—	$0	124,944	SEC↗
RUDY SUZANNE B	Director	A Award	2020-10-29	2020-10-30	25,462	—	$0	107,296	SEC↗
Denbaars Steven	Director	A Award	2020-10-29	2020-10-30	18,865	—	$0	267,829	SEC↗
McGuire James Michael	Director	A Award	2020-10-29	2020-10-30	19,235	—	$0	22,436	SEC↗
McMahon Jeffrey	Director	S Sale	2020-10-23	2020-10-23	22,136	$8.00	$177.1K	484,338	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-10-22	2020-10-23	50,000	$7.84	$392.0K	1,385,239	SEC↗
McMahon Jeffrey	Director	S Sale	2020-10-22	2020-10-23	7,854	$8.00	$62.8K	506,474	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-10-21	2020-10-23	50,000	$7.76	$388.0K	1,435,239	SEC↗
McMahon Jeffrey	Director	S Sale	2020-10-19	2020-10-21	10	$8.00	$80	514,328	SEC↗
Denbaars Steven	Director	S Sale	2020-10-12	2020-10-14	7,000	$8.53	$59.7K	248,964	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-10-01	2020-10-02	50,000	$8.07	$403.5K	1,485,239	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-09-30	2020-10-02	50,000	$8.39	$419.5K	1,535,239	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-09-28	2020-09-30	2,200	$8.37	$18.4K	238,177	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-09-25	2020-09-25	1,400	$8.04	$11.3K	192,021	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-09-24	2020-09-25	7,500	$8.02	$60.1K	2,929,562	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-09-23	2020-09-25	25,000	$8.20	$205.0K	2,937,062	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-09-14	2020-09-16	8,750	$7.64	$66.8K	240,377	SEC↗
McGuire James Michael	Director	A Award	2020-09-08	2020-09-10	3,201	—	$0	3,201	SEC↗
RUDY SUZANNE B	Director	A Award	2020-09-08	2020-09-10	718	—	$0	81,834	SEC↗
NEAL JERRY D	Director	A Award	2020-09-08	2020-09-10	718	—	$0	675,598	SEC↗
Geiss Arthur	Director	A Award	2020-09-08	2020-09-10	133	—	$0	99,359	SEC↗
Denbaars Steven	Director	A Award	2020-09-08	2020-09-10	133	—	$0	255,964	SEC↗
Boller Kenneth	Interim CFO	A Award deriv	2020-08-28	2020-09-01	25,000	—	$0	25,000	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award deriv	2020-08-28	2020-09-01	50,000	—	$0	50,000	SEC↗
Aichele David	EVP of Business Development	A Award deriv	2020-08-28	2020-09-01	40,000	—	$0	40,000	SEC↗
Houlden Rohan	Chief Product Officer	A Award deriv	2020-08-28	2020-09-01	40,000	—	$0	40,000	SEC↗
Boller Kenneth	Interim CFO	A Award	2020-08-28	2020-09-01	15,000	—	$0	77,000	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award	2020-08-28	2020-09-01	50,000	—	$0	2,962,062	SEC↗
Aichele David	EVP of Business Development	A Award	2020-08-28	2020-09-01	25,000	—	$0	193,421	SEC↗
Houlden Rohan	Chief Product Officer	A Award	2020-08-28	2020-09-01	25,000	—	$0	249,127	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-08-21	2020-08-25	1,500	$8.65	$13.0K	168,421	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-08-21	2020-08-25	1,400	$8.58	$12.0K	224,127	SEC↗
Boller Kenneth	Interim CFO	S Sale	2020-08-21	2020-08-25	1,400	$8.58	$12.0K	62,000	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-08-11	2020-08-13	1,900	$7.82	$14.9K	169,921	SEC↗
McMahon Jeffrey	Director	S Sale	2020-07-22	2020-07-24	20,000	$8.04	$160.8K	514,338	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-07-17	2020-07-21	2,200	$7.90	$17.4K	225,527	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-07-16	2020-07-17	2,350	$7.79	$18.3K	171,821	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-06-25	2020-06-26	9,000	$8.37	$75.3K	2,912,062	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-06-24	2020-06-26	25,000	$8.42	$210.5K	2,921,062	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-06-17	2020-06-18	50,000	$7.68	$384.0K	2,946,062	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-06-16	2020-06-18	50,000	$8.01	$400.5K	2,996,062	SEC↗
Denbaars Steven	Director	S Sale	2020-06-01	2020-06-03	7,000	$7.68	$53.8K	255,831	SEC↗
Aichele David	EVP of Business Development	S Sale	2020-04-15	2020-04-15	4,000	$7.59	$30.4K	174,171	SEC↗
McMahon Jeffrey	Director	S Sale	2020-04-14	2020-04-15	2,900	$8.00	$23.2K	534,338	SEC↗
McMahon Jeffrey	Director	S Sale	2020-04-13	2020-04-15	17,100	$8.01	$137.0K	537,238	SEC↗
Denbaars Steven	Director	S Sale	2020-04-13	2020-04-15	7,000	$7.59	$53.1K	262,831	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-04-02	2020-04-03	50,000	$4.65	$232.5K	3,046,062	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-04-01	2020-04-03	50,000	$4.72	$236.0K	3,096,062	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-03-26	2020-03-27	7,500	$4.74	$35.5K	3,146,062	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-03-25	2020-03-27	25,000	$4.64	$116.0K	3,153,562	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2020-03-13	2020-03-17	7,564	$4.20	$31.8K	0	SEC↗
RUDY SUZANNE B	Director	P Buy	2020-03-13	2020-03-17	5,000	$4.12	$20.6K	81,116	SEC↗
NEAL JERRY D	Director	P Buy	2020-03-13	2020-03-17	25,000	$4.25	$106.3K	674,880	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2020-03-13	2020-03-17	2,200	$4.22	$9.3K	227,727	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	D To issuer	2020-01-08	2020-01-10	1,000	—	$0	7,564	SEC↗
Denbaars Steven	Director	S Sale	2020-01-06	2020-01-06	7,000	$8.11	$56.8K	269,831	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award deriv	2019-12-20	2019-12-26	30,000	—	$0	30,000	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	A Award	2019-12-20	2019-12-26	30,000	—	$0	3,178,562	SEC↗
Boller Kenneth	Interim CFO	M Exercise deriv	2019-12-19	2019-12-20	4,000	—	$0	8,000	SEC↗
NEAL JERRY D	Director	A Award deriv	2019-12-19	2019-12-20	1,854	—	$0	1,854	SEC↗
RUDY SUZANNE B	Director	A Award deriv	2019-12-19	2019-12-20	1,854	—	$0	1,854	SEC↗
Boller Kenneth	Interim CFO	S Sale	2019-12-19	2019-12-20	500	$8.06	$4.0K	11,400	SEC↗
Boller Kenneth	Interim CFO	M Exercise	2019-12-19	2019-12-20	4,000	—	$0	11,900	SEC↗
Boller Kenneth	Interim CFO	S Sale	2019-12-19	2019-12-26	500	$8.06	$4.0K	63,400	SEC↗
RUDY SUZANNE B	Director	A Award	2019-12-19	2019-12-26	1,854	—	$0	76,116	SEC↗
NEAL JERRY D	Director	A Award	2019-12-19	2019-12-26	1,854	—	$0	649,880	SEC↗
Aichele David	EVP of Business Development	A Award deriv	2019-12-18	2019-12-20	20,000	—	$0	20,000	SEC↗
Houlden Rohan	Chief Product Officer	A Award deriv	2019-12-18	2019-12-20	20,000	—	$0	20,000	SEC↗
Boller Kenneth	Interim CFO	A Award deriv	2019-12-18	2019-12-20	15,000	—	$0	15,000	SEC↗
Aichele David	EVP of Business Development	A Award	2019-12-18	2019-12-26	20,000	—	$0	178,171	SEC↗
Boller Kenneth	Interim CFO	A Award	2019-12-18	2019-12-26	15,000	—	$0	63,900	SEC↗
Houlden Rohan	Chief Product Officer	A Award	2019-12-18	2019-12-26	20,000	—	$0	229,927	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2019-11-27	2019-11-27	5,000	$7.62	$38.1K	3,148,562	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2019-11-26	2019-11-27	25,000	$7.51	$187.8K	3,153,562	SEC↗
Aichele David	VP of Business Development	S Sale	2019-11-25	2019-11-27	1,900	$7.33	$13.9K	158,171	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2019-11-25	2019-11-27	2,000	$7.50	$15.0K	209,927	SEC↗
Boller Kenneth	Interim CFO	S Sale	2019-11-25	2019-11-27	500	$7.33	$3.7K	48,900	SEC↗
McMahon Jeffrey	Director	A Award	2019-11-04	2019-11-06	20,226	—	$0	554,338	SEC↗
NEAL JERRY D	Director	A Award	2019-11-04	2019-11-06	27,198	—	$0	648,026	SEC↗
Geiss Arthur	Director	A Award	2019-11-04	2019-11-06	25,251	—	$0	99,226	SEC↗
RUDY SUZANNE B	Director	A Award	2019-11-04	2019-11-06	21,545	—	$0	74,262	SEC↗
Denbaars Steven	Director	A Award	2019-11-04	2019-11-06	19,033	—	$0	276,831	SEC↗
Aichele David	VP of Business Development	S Sale	2019-10-07	2019-10-08	10,250	$7.74	$79.3K	160,071	SEC↗
Denbaars Steven	Director	S Sale	2019-10-07	2019-10-08	7,000	$7.72	$54.0K	257,798	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2019-09-30	2019-10-03	178	$7.76	$1.4K	13,314	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2019-09-27	2019-09-30	7,500	$7.62	$57.1K	3,178,562	SEC↗
Aichele David	VP of Business Development	S Sale	2019-09-27	2019-09-30	1,400	$7.74	$10.8K	170,321	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2019-09-27	2019-09-30	2,500	$7.61	$19.0K	211,927	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2019-09-26	2019-09-30	25,000	$7.77	$194.3K	3,186,062	SEC↗
Houlden Rohan	Chief Product Officer	S Sale	2019-09-12	2019-09-13	10,000	$8.20	$82.0K	214,427	SEC↗
Shealy Jeffrey B.	Chief Executive Officer	S Sale	2019-09-05	2019-09-06	460	$7.44	$3.4K	13,492	SEC↗
Boller Kenneth	Interim CFO	A Award	2019-08-20	2019-08-22	20,000	—	$0	49,400	SEC↗
Aichele David	VP of Business Development	A Award	2019-08-20	2019-08-22	20,000	—	$0	171,721	SEC↗
Houlden Rohan	Chief Product Officer	A Award	2019-08-20	2019-08-22	20,000	—	$0	224,427	SEC↗
Aichele David	VP of Business Development	S Sale	2019-08-12	2019-08-14	1,900	$5.49	$10.4K	151,721	SEC↗